Leveraging process engineering towards next-level autoinjector development
In the May issue of ONdrug Delivery magazine, SHL and its engineering leaders, Jonathan Kearns and Kevin Huang, discuss how SHL’s engineering competencies are being driven to the next level by leveraging process engineering and how this can benefit drug-device projects.
In this article, the authors discuss the generalized presumption that all engineering works are one and the same – highlighting the fact that there is a myriad of engineering functions and subdomains that critically contribute to the composite success of any industrial work. This consideration is especially important in the field of medicine where the complexities of combination product development require a tight-knit collaboration between pharma and medtech. In the course of explaining how process engineering plays a role in autoinjector development, such as in the DAI®, Molly®, and Maggie® device, the authors narrate a large-scale program consolidation and ramp-up conducted with one of SHL’s longstanding customers to date.
Jonathan and Kevin conclude the article by restating SHL Medical’s active commitments towards engineering innovative device technologies – autoinjectors that address varying primary containers, drug fill volumes and viscosities, as well as improved usability across patients of different therapy areas.
Learn more by reading our latest thought-leadership piece about SHL’s process engineering competencies here.
